[1] Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med, 2004, 350(15):1535-1548 [2] Borowitz MJ, Wood BL, Devidas M, et al. Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232. Blood, 2015, 126(8):964-971 [3] Flohr T, Schrauder A, Cazzaniga G,et al. Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia,2008,22(4):771-782 [4] O'Connor D1, Enshaei A, Bartram J, et al. Genotype-specific minimal residual disease interpretation improves stratification in pediatric acute lymphoblastic leukemia. J Clin Oncol,2018,36(1):34-43 [5] van Krieken JH, Langerak AW, Macintyre EA, et al. Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia,2007,21(2):201-206 [6] Langerak AW, Groenen PJ, Brüggemann M, et al. EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations. Leukemia,2012,26(10):2159-2171 [7]中华医学会儿科学分会血液学组,中华儿科杂志编辑委员会. 儿童急性淋巴细胞白血病诊疗建议(第四次修订). 中华儿科杂志,2014,52(9):641-644 [8] 李志刚,吴敏媛,朱平,等. 白血病29种染色体畸变形成的融合基因分析.中华儿科杂志, 2001,39(11):682-685 [9] Spits H. Development of alphabeta T cells in the human thymus. Nat Rev Immunol,2002,2(10):760-772 [10] Dik WA, Pike-Overzet K, Weerkamp F, et al. New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profiling. J Exp Med,2005,201(11):1715-1723 [11] Kolenova A, Hikkel I, Ilencikova D, et al. Minimal residual disease detection using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: Slovak experience. Neoplasma,2010,57(6):552-561 [12] Szczepański T, Pongers-Willemse MJ, Langerak AW, et al. Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor alpha beta lineage. Blood,1999,93(12):4079-4085 [13] Flohr T, Schrauder A, Cazzaniga G, et al. Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia,2008,22(4):771-782 [14] 刘婕好,李志刚,高超,等. 儿童急性T淋巴细胞白血病T细胞受体β链基因重排的特点及其在微小残留病定量检测中的意义.中华儿科杂志,2008,46(z1):18-24 [15] Sudhakar N, Nancy NK, Rajalekshmy KR, et al. T-cell receptor gamma and delta gene rearrangements and junctional region characteristics in south Indian patients with T-cell acute lymphoblastic leukemia. Am J Hematol,2007,82(3):215-221 [16] Meleshko AN, Lipay NV, Stasevich IV, et al. Rearrangements of IgH, TCRD and TCRG genes as clonality marker of childhood acute lymphoblastic leukemia. Exp Oncol,2005,27(4):319-324 [17] Szczepański T, Langerak AW, Willemse MJ,et al. T cell receptor gamma (TCRG) gene rearrangements in T cell acute lymphoblastic leukemia refelct 'end-stage' recombinations: implications for minimal residual disease monitoring. Leukemia,2000,14(7):1208-1214 [18] van der Velden VH, Wijkhuijs JM, Jacobs DC, et al. T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis. Leukemia,2002,16(7):1372-1380 [19]Szczepański T, van der Velden VH, Raff T, et al. Comparative analysis of T-cell receptor gene rearrangements at diagnosis and relapse of T-cell acute lymphoblastic leukemia (T-ALL) shows high stability of clonal markers for monitoring of minimal residual disease and reveals the occurrence of second T-ALL. Leukemia, 2003,17(11):2149-2156 |